Tag: Pediatric Oncology

Pediatrics

Cardioprotective Drug Prevents Severe Cardiac Events in Children Undergoing Chemotherapy for Acute Myeloid Leukemia

Newsemia
The cardioprotective drug dexrazoxane preserved cardiac function in pediatric patients undergoing chemotherapy for acute myeloid leukemia (AML) without compromising overall patient survival and potentially improving...
Pediatrics

Stephan Grupp, MD, PhD, Elected to the National Academy of Medicine

Newsemia
Stephan Grupp, MD, PhD, Chief of the Cell Therapy and Transplant Section in the Division of Oncology and Director of the Cancer Immunotherapy Program at...
Pediatrics

Proton Therapy Demonstrates Efficacy and Reduced Toxicity in Largest-Ever Cohort of Pediatric High-Risk Neuroblastoma Patients

Newsemia
Researchers from Children’s Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania analyzed the largest cohort to date of pediatric...
Pediatrics

Antibody-Drug Conjugate, from a Growing Class of Highly Potent Anticancer Drugs, Shows Efficacy against Cell Surface Protein in Neuroblastoma

Newsemia
Physician-scientists in the Cancer Center at Children’s Hospital of Philadelphia have developed a preclinical, potent therapy attached to an antibody that targets a surface protein...
Pediatrics

Immunotherapy Pioneers Unveil Updated Efficacy Data of Single Infusion of Tisagenlecleucel CAR T-cell Therapy

Newsemia
Physician-scientists from Children’s Hospital of Philadelphia presented updated efficacy and safety data on Kymriah (tisagenlecleucel) –the first-ever FDA-approved personalized CAR T-cell gene immunotherapy for aggressive...
Pediatrics

First Automated Malnutrition Screen Automated for Hospitalized Children

Newsemia
A team of clinicians, dietitians and researchers has created an automated program to screen for malnutrition in hospitalized children, providing daily alerts to healthcare providers...
Pediatrics

Pioneers at Children's Hospital of Philadelphia Greet European Commission's Approval of Kymriah as Landmark Medical Advance for Young Cancer Patients in Europe

Newsemia
Oncologists from Children’s Hospital of Philadelphia today celebrated a watershed moment in medicine: approval by the European Commission of Kymriah (tisagenlecleucel, formerly CTL019) –the first-ever...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World